acridine lactate provided by Federa, Brussels). A sample of IgG was aggregated by heating a 1% solution at 63°C for 30 min. Beef heart cytochrome c was purchased from Sigma Chemical Co., St. Louis, Mo. Ficoll was provided by Pharmacia Fine Chemicals, Uppsala, Sweden, and Isopaque by Nyegaard & Co., Oslo, Norway.
Cells. Peritoneal cells were collected according to the procedure of Cohn and Benson (20) . A vol of 4 ml basal medium of Eagle (BME) containing 2 mg/ml heparin was injected into the peritoneal cavity of NMRI female mice weighing about 30 g, and reaspirated after abdominal kneading. On the average, 5 × 108 MPC were harvested from one animal. They consisted of about 70% macrophages and 30% lymphocytes.
Suspensions of mouse spleen cells in BME were centrifuged on a Ficoll Isopaque mixture (p = 1,077) for 40 min at 400g. After centrifugation, the cells present at the interface between the Ficoll Isopaque and the medium were washed twice in BME and finally resuspended in BME containing 1% bovine serum albumin (BSA, provided by Calbiochem, San Diego, Calif.) before incubation with FeLf. These cells consisted of more than 90% lymphocytes. L1210 mouse lymphoma cells are maintained in culture in our laboratory.
Methods. Succinylation of FeLf was carried out by treating 50 mg protein in 3 ml of 0.2 M NaC1 and 0.1 M NaHCO3 with 25 mg of succinic anhydride at room temperature for 1 h. The pH was maintained at 8.5 by addition of 0.1 M NaOH.
For carbamylation, 10 mg FeLf was incubated in phosphate-buffered saline, pH 7.2, at 45°C with 1 M potassium cyanate. Various samples of FeLf differing by their degree of chemical modification were prepared by changing the time of incubation. The reaction was stopped by passing the reagents through a column of Sephadex G-25.
To remove neuraminic acid from FeLf, 50 mg protein dissolved in 5 ml of sodium acetate buffer was incubated at 37°C for 48 h with 500 U of neuraminidase from Vibrio cholerae (BehringInstitut). The solution was then dialyzed for 24 h against 0.05 M ammonium bicarbonate, and lyophilized. Previous experiments (21) had shown that after such a treatment no sialic acid remained on FeLf. This solution will be referred to as NANA-free FeLf. 59FeLf and 59FeTf were prepared by adding SSFe-citrate to the apoproteins, in the presence of bicarbonate, up to about 80% of their binding capacities. Tf and Lf were iodinated with carrier-free 'zsI using the chloramine T technique (22) . Free iodine was separated from the protein by gel filtration on Sephadex G-25.
Iodine-labeled proteins were.stored at -20°C. In the first experiments, the amount of protein bound by the cells was calculated according to the method of Arend and Mannik (23) , where cells were repeatedly washed and corrections made for nonspecific adsorption. However, in our experiments with Lf, ai~r having applied the Arend and Mannik method, we realized that only a single washing of the pellet and the tube without cells followed by substraction of the counts detected in the tubes without MPC were required. Therefore, in further experiments, the amount of Lf specifically bound to MPC was determined by this simplifed method.
Results

Kinetics of LfBinding to MPC.
Peritoneal cells were incubated at 37°C with '2sI-or 59Fe-labeled FeLf in BME containing 1% BSA. At various time intervals, the reaction was stopped by diluting the reagents 10 times with BME containing BSA. The cells were immediately centrifuged at 100 g for 5 rain at 4°C, and the radioactivity of the pellet counted (Fig. 1) . After 30 rain, the binding curve tended to flatten. No significant difference in the binding was observed between the 5SFe-or '2~I-labeled preparations.
To see whether FeLf was adsorbed onto the membranes or ingested, the cells were incubated for 30 min at either 37°C or 4°C with ~9FeLf (Fig. 2) . No significant difference was observed, suggesting that the protein was only bound to the cell membrane.
Binding of Lf to MPC as a Function of Lf Concentration.
In a series of seven experiments, 5SFeLf was added in increasing amounts to MPC and incubated at 37°C for 30 min. Aider centrifugation and washing, the radioactivity was mea- •' 0 concentrations. MPC were preincubated with the potential inhibitor at 4°C for 15 min in BME containing 1% BSA. Then, 500 ~g of radioactive FeLf was added, and the incubation prolonged for another 30 min. The percent of inhibition was plotted vs. the concentration of the competitive protein (Fig. 4) . At the same concentration of both reagents, unlabeled FeLf inhibited by 50% the binding of radioactive FeLf. Human IgG did not interfere significantly. NANA-free FeLf displayed an inhibitory activity clearly higher than native FeLf. A second series of inhibition experiments was carried out using only one concentration of the competitive protein, i.e., 500 ~g/ml (Table I) . ApoLf inhibited the binding of radioactive FeLfto a lower extent than did cold FeLf. The difference was at the limit of statistical significance (0.05 < P < 0.10). Surprisingly, when the sample of Lf which was deprived of its iron by dialysis against citric acid was used, no inhibition was observed. Furthermore, no inhibitory activity was recovered even when iron was added to this Lf sample, of which the iron saturation was shown by the reappearance of the characteristic pink hue.
After succinylation or carbamylation, Lf retained its iron as shown by its absorbance spectrum. However, the protein lost its inhibitory activity as a reciprocal function of its chemical modification. Various samples of carbamylated FeLf were analyzed in electrophoresis in agarose gel at pH 8.6 together with native FeLf and sialic acid-free FeLf. When the inhibitory activity of each preparation was plotted vs. their electrophoretic mobility, a linear relationship was observed (Fig. 5) , indicating that the affinity of FeLf for mouse peritoneal cells decreased with the suppression of positive electric charge of the protein.
However, a protein with a high isoelectric point such as beef heart cytochrome c (pI = 10.6, reference 24) failed to inhibit the binding of FeLf. To confirm that apoLf had a lower affinity towards the peritoneal cells than FeLf, the experiments of competition between FeLf and apoLf were resumed using two kinds of labeled reagents, i.e., 59FeLf-and 125I-labeled apoLf (Table  II) . 75% inhibition of 125I-apoLfbinding was obtained with FeLl. This result was significantly higher than the 51.6% inhibition resulting from the preincubation with apoLf (0.001 < P < 0.01). ApoLf inhibited the binding of 59FeLf at a rate of 32.2%, whereas cold FeLf reached 56.3%. This difference was also significant (0.02 < P < 0.05).
Comparison of the Binding of FeLf to Various Mouse Cells. ~25I-labeled FeLf
was added in constant concentration (100 ~g per ml) to an increasing number of mouse cells from different origins, i.e. peritoneal cells, isolated spleen lymphocytes, and L1210 lymphoma cells. The radioactivity associated with the pellet was calculated after washing and appropriate corrections (see Materials and Methods). A linear relationship was observed between the amount of cellassociated Lf and the number of cells (Fig. 6) . The slopes that indicated the number of FeLf molecules bound per cell differed widely depending on the type The figures in parentheses correspond to the number of experiments. The Parameters of the Binding of Lf to Peritoneal Macrophages and Lymphocytes. The MPC were fractionated on a column of glass beads in order to separate the macrophages from lymphocytes. The macrophages, which adhered to the glass, were recovered by elution with 10 mM Na-EDTA in balanced salt solution without Ca ++ and Mg ÷+. The viability of these macrophages was checked by trypan blue exclusion. On the average, 20% of these cells were dead, whereas less than 4% of the lymphocytes that freely passed through the column failed to exclude the dye. Owing to the poor yield of viable macrophages, the study of the parameters of Lf binding was restricted to unfractionated MPC and to purified peritoneal lymphocytes. Knowing the quantity of Lf that these lymphocytes could retain, it was possible to calculate the quantity of Lfbound to the other cells constituting the MPC, i.e., the macrophages (Fig. 7) . About 10% of FeLf was bound to lymphocytes.
A Schatchard plot was constructed for the binding of 125I-of 59Fe-labeled FeLf to lymphocytes and macrophages (Table III and (c) The integrity of the structure of Lf was critical for its reaction with MPC. Succinylation, carbamylation, and even dialysis against 0.1 M citric acid resulted in a marked decrease in the affinity of the protein for the cells. This property of FeLf to combine with the cell membrane is much more sensitive to structural changes than the ability of the protein to bind iron since, after dialysis against citric acid, the protein was still able to bind iron, but the complex failed to react with MPC. Similar observations were reported by Schade (25) when he studied the combination of Tf with the membrane of reticulocytes. This author noticed that certain samples of Tf easily lost their ability to react with reticulocytes while keeping their iron-binding capacity. Further experiments with carbamylated FeLf and NANA-free FeLf revealed the importance of the electric charge of the protein for its binding to MPC. It is known that Lf tends to form complexes with many acidic molecules such as agaropectin, trypan blue (26) , and albumin (27) . Hence, the high isoelectric point (pI = 9.0) of Lf (21) could in part account for the reaction of FeLf with MPC. However, basic nature of the protein is not the only requirement for binding, since beef heart cytochrome c, which has a pI of 10.6 (24), did not inhibit the binding of FeLf.
(d) The ability of apoLf to inhibit the binding of FeLf to MPC was significantly lower than that of FeLf. This could be explained by the steric changes that Lf undergoes when it combines with iron. The molecule of FeLf is more compact and more asymetric than that of APOLf (5).
(e) Both sheep and human red blood cells did not bind Lf, whereas lymphocytes and leukemic cells were capable of binding Lf, albeit to a lower extent than do macrophages ( Fig. 6 and 7) . Peritoneal macrophages were found to bind on the average 20 × 106 molecules of FeLf per cell, whereas peritoneal lymphocytes bound only 6.7 x 106 molecules per cell. The calculated values for the affinity constants of Lf for macrophages and lymphocytes (0.9 × l0 s liters/mol is of the same order of magnitude as the affinity constant of monomeric IgG for macrophages (23) . However, the numbers of bound IgG molecules is 10 times lower than that of Lf molecules. Apparently, there is no relationship between the Fc and Lf receptors of macrophages, since monomeric as well as aggregated IgG failed to inhibit the binding of Lf.
The present work confirms and extends our previous observations that FeLf has a high affinity for the membrane of macrophages (18, 19) . Previous experiments had shown that human Lf which was injected into rats was quickly removed by the RES with a clearance rate dependent upon the iron content of the protein and its structural integrity. The plasma half-life of apoLf was significantly prolonged, as well as that of succinylated FeLf, when compared to that of intact FeLf. Furthermore, after blockade of the RES, the half-life of FeLf was markedly increased.
The presence of a Lf receptor on macrophages is of interest as it could explain certain features of iron metabolism, particularly the hyposideremia of inflammation. This phenomenon is classically explained by the impairment of the reutilization of iron from hemoglobin catabolized in the RES. There is apparently a blockade in the release of iron from the RES. Fillet et al. (28) have shown that, in dogs, after the catabolism of hemoglobin in the RES, the iron returns to the plasma via two pathways, one very fast (tl/2, 24 min) and the other very slow (tl/2, 7 days). These pathways are of equal magnitude in normal animals, while in an acute inflammatory reaction there is a marked increase in the proportion of iron processed through the slow pathway. We propose that Lf, which is released from neutrophils, is adsorbed onto the membrane of macrophages. There it takes the iron released from these cells and immediately the FeLf complex is reintroduced into the RES where it accumulates in the form of ferritin, as will be described elsewhere. This storage could correspond to the slow pathway described by Fillet et al. (28) .
The presence of Lf on the membrane of macrophages must also be considered in the light of the ability of this protein to inhibit the growth of bacteria by competing for the iron necessary for bacterial development (7, 8) . This activity, which is common to Lf and Tf, would be reinforced in the presence of antibodies (9) . At present no role can be attributed to the binding of Lf to lymphocytes.
Summary
Human iron-saturated Lf (FeLf), which was labeled with 125I or 59Fe, was found to combine with the membrane of mouse peritoneal cells (MPC) which consisted of 70% macrophages. The following experimental data suggested the involvement of a specific receptor. The existence of a Lf receptor capable of concentrating Lf released from neutrophils on the membrane of macrophages could explain the apparent blockade of the release of iron from the reticuloendothelial system, which accounts for the hyposideremia of inflammation. A receptor for FeLfwas also found on mouse peritoneal lymphocytes. The affinity constant of FeLf for both lymphocytes and macrophages was 0.9 x 106 liters/mol. However, macrophages bound three times more FeLf molecules (20 x 106) per cell than did lymphocytes (7 x 106).
